Corey Lovitt
7Patents
1h-index
9Co-inventors
36Inventor score
Filing activity: Jul 1, 2003 → May 16, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8207314B2 | Tumor antigens for prevention and/or treatment of cancer | Human Necessities | 13 | Active |
| US8021664B2 | Tumor antigens Bfa5 for prevention and/or treatment of cancer | Human Necessities | 1 | Expired |
| US7851213B2 | Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer | Chemistry; Metallurgy | 1 | Active |
| US8946174B2 | Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US7790857B2 | Monoclonal antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US8361706B2 | Monoclonal antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US8802383B2 | Monoclonal antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.